Synapse - Clinical Pharmacy Specialists

Search Within

Clinical Pharmacy Specialists

Results (293)

T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML

Journal Article

Satty, A. M.; Klein, E.; Mauguen, A.; Kunvarjee, B.; Boelens, J. J.; Cancio, M.; Curran, K. J.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; more...
Bone Marrow Transplantation (2024)

Fulltext@MSK | Save

Brief report: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to “false” decreases in renal function

Journal Article

Chen, M. F.; Harada, G.; Liu, D.; DeMatteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A.; Gutgarts, V.
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort

Journal Article

Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A. S.; Panageas, K. S.; Grommes, C.
Annals of Lymphoma (2023)

Fulltext@MSK | Save

Multicenter retrospective evaluation of treatment of high-risk acute promyelocytic leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Meeting Abstract

Benitez, L.; Marx, K. R.; Buhlinger, K. M.; Clark, S. M.; Reid, J. H.; Rausch, C. R.; Gatwood, K. S.; Stump, S. E.; Shah, R.; Ciervo, J.; more...
Blood (2023)

Fulltext@MSK | Save

Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
Blood (2023)

Fulltext@MSK | Save

Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Meeting Abstract

Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
Blood (2023)

Fulltext@MSK | Save

Evaluating tumor-intrinsic and patient-specific mechanisms of resistance to teclistamab in anti-BCMA exposed and naïve multiple myeloma

Meeting Abstract

Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I. S.; Wang, A.; Zhu, M.; Patel, D.; Tan, C.; Hultcrantz, M.; more...
Blood (2023)

Fulltext@MSK | Save

Precision management of a patient with dihydropyrimidine dehydrogenase deficiency and liver-predominant metastatic rectal cancer using hepatic arterial floxuridine

Journal Article

Lumish, M.; Thackray, J.; Do, R. K. G.; Caudle, K. E.; Amstutz, U.; Schwab, M.; Diasio, R. B.; Jarnagin, W. R.; Cercek, A.
JCO Precision Oncology (2023)

Fulltext@MSK | Save

Response of thrombopoietin receptor agonists in MDM2 inhibitor induced thrombocytopenia

Meeting Abstract

DeMatteo, R.; Sgroe, E.; Merrill, M. B.; Gounder, M.; Liu, D.
Annals of Oncology (2023)

Fulltext@MSK | Save

Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients

Journal Article

Laracy, J. C.; Yan, J.; Steiger, S. N.; Tan, C. A.; Cohen, N.; Robilotti, E. V.; Fender, J.; Cohen, S.; Korde, N.; Lee-Teh, M.; more...
Haematologica (2023)

Fulltext@MSK | Save